Stock Market News

Novartis set to initiate mass production of cancer drugs in Japan by 2026 - Nikkei

Mar 5, 2025 - 17:54
 0
Novartis set to initiate mass production of cancer drugs in Japan by 2026 - Nikkei
Read More

Tags:

Previous Article

Weyco Group, Inc. (WEYS) Q4 2024 Earnings Call Transcript

Next Article

Poland stocks higher at close of trade; WIG30 up 3.37%

Related Posts

Canada imposes 25% tariffs on $30 billion of US goods, $125 billion more on tap

Canada imposes 25% tariffs on $30 billion of US goods, ...

Mar 4, 2025  0

NetEase earnings beat by ¥2.67, revenue fell short of estimates

NetEase earnings beat by ¥2.67, revenue fell short of e...

Feb 20, 2025  0

Baidu acquires JOYY's live-streaming business in China for $2.1 billion

Baidu acquires JOYY's live-streaming business in China ...

Feb 25, 2025  0